Re: Wei Shen Tan, Aaron Prendergast, Charlotte Ackermann, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003.

Campodonico, Fabio; Mattioli, Francesca; Introini, Carlo

Campodonico, Fabio; Mattioli, Francesca; Introini, Carlo.

Afiliación

Campodonico F; Department of Abdominal Surgery, Urology Unit, Galliera Hospital, Genoa, Italy. Electronic address: fabio.campodonico@galliera.it.
Mattioli F; Department of Internal Medicine, Pharmacology & Toxicology Unit, University of Genoa, Genoa, Italy; Clinical Pharmacology Unit, Galliera Hospital, Genoa, Italy.
Introini C; Department of Abdominal Surgery, Urology Unit, Galliera Hospital, Genoa, Italy.

Eur Urol ; 83(2): e56-e57, 2023 02.

Article en En | MEDLINE | ID: mdl-36372625

Asunto(s)

Neoplasias Vesicales sin Invasión Muscular; Neoplasias de la Vejiga Urinaria; Humanos; Neoplasias de la Vejiga Urinaria/tratamiento farmacológico; Mitomicina; Administración Intravesical; Adyuvantes Inmunológicos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Neoplasias Vesicales sin Invasión Muscular Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Urol Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google